Caplin Point Laboratories Ltd's sterile product manufacturing subsidiary Caplin Steriles Ltd has received approval from the US Food and Drug Administration to market Thiamine Hydrochloride injection USP, the company said via an exchange filing.
The injection is a generic of Thiamine Hydrochloride injection of Fresenius Kabi USA LLC.
Thiamine Hydrochloride injection is used in the treatment of Thiamine, or Vitamin B1, deficiency and beriberi, a serious condition caused by a prolonged lack of Vitamin B1 in the body.
The Thiamine Hydrochloride injection had sales of $38 mln for the year ending September in the US, according to data by IQVIA.
Bombay HC Issues Notice To State Government Over Lack Of Toilets Oon Mumbai-Pune Expressway
Mumbai Cyber Fraud: Father-Daughter Duo Loses ₹11.93 Lakh In Fake Medical Insurance Scam; Case Registered
Mumbai Crime: Police Book 45 For Vandalising Commercial Building In Kandivali, Damages Estimated At ₹1.5 Crore
Madhya Pradesh News: CBI Court Sentences Former Sub-Post Master To 5 Years Of Imprisonment For Fraudulent Withdrawals
Shares of Caplin Point Laboratories traded 0.8% higher at ₹671.15 on NSE, at 11:15 IST.
